PKMYT1 in Cancer: Beyond Cell Cycle Checkpoints to Context-Dependent Therapeutic Vulnerability. [PDF]
Li L, He B, Hao M, Liu Y, Song S, He R.
europepmc +1 more source
Curriculum Vitae of WEE2 Kinase in Homeostasis and Diseases: A Systematic Review. [PDF]
Wang R +8 more
europepmc +1 more source
Targeting a CDH1-TK1-dependent DNA Synthesis Pathway Overcomes Chemoresistance in Acute Myeloid Leukemia. [PDF]
Feng X +5 more
europepmc +1 more source
A regulatory network underlying idiopathic pulmonary fibrosis. [PDF]
Li G +10 more
europepmc +1 more source
Biomarker-Driven Treatments for Ovarian Cancer: Moving Beyond HRD? [PDF]
Joseph L, Flynn M, Ledermann JA.
europepmc +1 more source
Systematic analyses to explore kinase gene set-based signature in glioma, in which WEE1 contributes to tumor progression. [PDF]
Zhang D +8 more
europepmc +1 more source
Mechanisms of resistance to PARP inhibitors in advanced epithelial ovarian cancer: biological determinants and therapeutic implications. [PDF]
Incognito D +13 more
europepmc +1 more source
Emerging Therapeutic Strategies in Small-Cell Lung Cancer: From Adaptive Resistance to Precision Therapy. [PDF]
Kim J, Kang S.
europepmc +1 more source
Circulating miR-22 Early Predicts TACE Non-Response and Targets WEE1 in Hepatocellular Carcinoma. [PDF]
Gramantieri L +20 more
europepmc +1 more source
Overcoming Resistance in Triple-Negative Breast Cancer: A Translational Perspective on Next-Generation DNA Damage Response Inhibitors and Synthetic Lethality. [PDF]
Jończyk J +4 more
europepmc +1 more source

